Stocks Are Going Back on Sale As Vaccine Rallies Fade

Stocks like Aphria (TSX:APHA)(NASDAQ:APHA) are going back on sale as post-election vaccine bullishness begins to recede.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Uncertainty in the markets can cause investors to make snap decisions. The U.S. election saw the markets flipflop as the democrat landslide failed to materialize. While Joe Biden has since emerged as as the president-elect, the politics of our southerly neighbours remain starkly divided. The pandemic has also thrown mixed messages into the news cycle, with rising cases pitched against vaccine hopes.

Stock market volatility continues

But uncertainty itself is not the problem. The markets were bathed in uncertainty last year. From weak oil to the trade war to valuation anxiety, 2019 had worries aplenty. But investors carried on buying right up until the March crash. Instead, the real problem right now is indecision. This can be seen in the way that the TSX Composite Index has flattened out this week.

Investors are beginning to ease back out of value stocks. But growth stocks are also slowing down at the same time. The markets are holding their breath. Markets are weighing such disparate stocks as Aphria against names like Barrick Gold and Newmont. Both asset types have seen intense momentum this year but are now grinding to a halt.

This holding pattern is fairly rare in 2020. The year to date has been typified by wildly oscillating momentum. Huge dips have been offset by heroic rips. But the current sentiment is becoming somewhat neutral. While greed has lately predominated over fear, stocks are nevertheless caught between rapidly alternating patterns.

Indeed, the CBOE Volatility Index (VIX) is currently pointing to 22.19. This sometimes overlooked indicator shows a neutral market right now. The amount of 52-week highs compared to yearlong lows is also fairly neutral at the moment. This neutrality belies a market that could flip either way.

Keep cash on hand for buying opportunities

The situation probably won’t last long, though. The vaccine bullishness that has been buoying the markets is already beginning to turn into a disillusioned selloff. With businesses still reporting earnings, there may be some upside still to be gleaned, especially from bank stocks. A resolved political situation south of the border could also help to lift stocks.

However, vaccine hopes are still 2020’s fairy gold, turning into sacks of leaves overnight. Until the uncertainties in the market are erased – from U.S. election shenanigans to the pandemic itself – then the selloffs will keep erasing the rallies.

It will take a successful vaccination program to kickstart a sustained bull run. And even then, the uncertainties that preexisted the pandemic will have to be mitigated.

Until then, bargains can still be had. Look at Aphria, for instance, down 1.3% at the time of writing. Barrick is down by the same amount,which renders both stocks key contrarian picks this week. As the reality of the pandemic continues to sink in, investors are going to be selling a lot of quality picks.

Value opportunities are therefore likely to continue opening up. By buying shares while they’re in the red, investors can continue to keep calm and carry on building positions.

Should you invest $1,000 in CIBC right now?

Before you buy stock in CIBC, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and CIBC wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »